Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions
出版年份 2016 全文链接
标题
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions
作者
关键词
-
出版物
ANNALS OF THE RHEUMATIC DISEASES
Volume 75, Issue 8, Pages 1428-1437
出版商
BMJ
发表日期
2016-06-04
DOI
10.1136/annrheumdis-2016-209201
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
- (2015) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study
- (2015) Judith Haschka et al. ANNALS OF THE RHEUMATIC DISEASES
- Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial(STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study)
- (2015) Bruno Fautrel et al. ANNALS OF THE RHEUMATIC DISEASES
- Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
- (2015) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study
- (2015) K. Yoshida et al. JOURNAL OF RHEUMATOLOGY
- Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis
- (2015) Esperanza Naredo et al. RHEUMATOLOGY
- Klinische Remission bei rheumatoider Arthritis
- (2015) K. Albrecht et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
- (2015) N. van Herwaarden et al. BMJ-British Medical Journal
- Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
- (2015) N. van Herwaarden et al. BMJ-British Medical Journal
- THU0152 The Poet-Us Study: Can Ultrasonography Predict Flare in Patients with RA and Persistent Low Disease Activity in Whom the Tnfinhibitor (TNFI) is Stopped? Preliminary Results of an Ongoing Study
- (2014) F. B. G. Lamers-Karnebeek et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial
- (2014) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
- (2014) T W J Huizinga et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
- (2014) Paul Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry
- (2014) Arthur Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis
- (2014) Yoshiya Tanaka et al. DRUGS
- Sustained Remission with Etanercept Tapering in Early Rheumatoid Arthritis
- (2014) Paul Emery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prediction of Relapse After Discontinuation of Biologic Agents by Ultrasonographic Assessment in Patients With Rheumatoid Arthritis in Clinical Remission: High Predictive Values of Total Gray-Scale and Power Doppler Scores That Represent Residual Synovial
- (2014) Taro Iwamoto et al. ARTHRITIS CARE & RESEARCH
- Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010
- (2013) Anna-Birgitte Aga et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
- (2013) Yoshiya Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
- (2013) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Patients with Rheumatoid Arthritis
- (2013) L. Aguilar-Lozano et al. JOURNAL OF RHEUMATOLOGY
- Five-year Favorable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data from the ESPOIR Cohort
- (2013) B. Combe et al. JOURNAL OF RHEUMATOLOGY
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
- (2013) Josef S Smolen et al. LANCET
- Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
- (2013) Josef S Smolen et al. LANCET
- Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study
- (2013) Norihiro Nishimoto et al. Modern Rheumatology
- Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
- (2012) Jacqueline Detert et al. ANNALS OF THE RHEUMATIC DISEASES
- Down-titration and discontinuation of infliximab in rheumatoid arthritis patients with stable low disease activity and stable treatment: an observational cohort study
- (2012) Aatke van der Maas et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
- (2011) M. van den Broek et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
- (2011) David T. Felson et al. ARTHRITIS AND RHEUMATISM
- Drug-free remission: is it already possible?
- (2011) Marianne van den Broek et al. CURRENT OPINION IN RHEUMATOLOGY
- When to initiate and discontinue biologic treatments for rheumatoid arthritis?
- (2011) K. Chatzidionysiou et al. JOURNAL OF INTERNAL MEDICINE
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- 'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought
- (2011) S. Hewlett et al. RHEUMATOLOGY
- Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study
- (2010) N. B. Klarenbeek et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
- (2010) B. Saleem et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- (2010) Y. Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Weekly home self-assessment of RAPID-4/3 scores in rheumatoid arthritis: A 6-month study in 26 patients
- (2010) Anne Blanchais et al. JOINT BONE SPINE
- Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis
- (2010) V. Bejarano et al. RHEUMATOLOGY
- Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2009) R. O'Mahony et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts
- (2009) Diane van der Woude et al. ARTHRITIS AND RHEUMATISM
- Effect of discontinuing TNFα antagonist therapy in patients with remission of rheumatoid arthritis
- (2009) Olivier Brocq et al. JOINT BONE SPINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started